middle.news
How AdAlta’s New Partnership Could Speed Up CAR-T Therapy for Mesothelioma
9:56am on Friday 27th of March, 2026 AEDT
•
Biotechnology
Read Story
How AdAlta’s New Partnership Could Speed Up CAR-T Therapy for Mesothelioma
9:56am on Friday 27th of March, 2026 AEDT
Key Points
First Joint Development Committee meeting marks shift to joint execution
Manufacturing transfer to Australia may accelerate by up to six months
Two-stage US FDA engagement strategy to reduce regulatory uncertainty
Pending updated clinical results from China Investigator Initiated Trials
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE